Related Experiment Videos
Retrograde autologous priming reduces blood use
The Annals of Thoracic Surgery
|October 13, 1998
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Inferior Outcomes on the Waiting List in Low-Volume Pediatric Heart Transplant Centers.
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2017
Upregulation of transcription factors in lung in the early phase of postpneumonectomy lung growth.
American journal of physiology. Lung cellular and molecular physiology·2001
Transmyocardial laser revascularization dose response: enhanced perfusion in a porcine ischemia model as a function of channel density.
The Annals of thoracic surgery·2001
Percutaneous endocardial transfer and expression of genes to the myocardium utilizing fluoroscopic guidance.
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions·2001
Use of quantitative TaqMan real-time PCR to track the time-dependent distribution of gene transfer vectors in vivo.
Molecular therapy : the journal of the American Society of Gene Therapy·2000
In Memoriam: L. Penfield Faber, MD (October 30, 1931-June 32026, ).
The Annals of thoracic surgery·2026
A NEW ERA FOR THE SURGICAL TREATMENT OF ATRIAL FIBRILLATION: EVOLVING SURGICAL TECHNIQUES AND CLINICAL CONSIDERATIONS.
The Annals of thoracic surgery·2026
Reducing sternal wound infections after cardiac surgery through targeted, interdisciplinary efforts: A large, single-center experience.
The Annals of thoracic surgery·2026
Bridge or Burden? Heart Transplant Outcomes Following Left Ventricular Assist Device Explant in the Contemporary Allocation Era.
The Annals of thoracic surgery·2026
Dropout after Neoadjuvant Chemoimmunotherapy for Non-Small Cell Lung Cancer in the Veterans Health Administration.
The Annals of thoracic surgery·2026
CHIO3: CHemotherapy Combined with Immune Checkpoint Inhibitor for Operable Stage IIIA/B (N2) Non-Small Cell Lung Cancer: Surgical Outcomes.
The Annals of thoracic surgery·2026